Resistance Analysis and Characterization of a Thiazole Analogue, BP008, as a Potent Hepatitis C Virus NS5A Inhibitor

Hepatitis C virus (HCV) is a global health problem, affecting approximately 3% of the world's population. The standard treatment for HCV infection is often poorly tolerated and ineffective. Therefore, the development of novel or more effective treatment strategies to treat chronic HCV infection...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Lin, Hui-Mei, Wang, Jing-Chyi, Hu, Han-Shu, Wu, Pei-Shan, Yang, Chi-Chen, Wu, Chung-Pu, Pu, Szu-Yuan, Hsu, Tsu-An, Jiaang, Weir-Torn, Chao, Yu-Sheng, Chern, Jyh-Haur, Yeh, Teng-Kuang, Yueh, Andrew
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2012
Assuntos:
Antiviral Agents
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3256078/
https://ncbi.nlm.nih.gov/pubmed/22006008
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00599-11
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares